S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis

NCT06872138 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-05-21

No results posted yet for this study

Summary

This study aims to evaluate both serum and urine S100A8 as potential biomarkers for Lupus nephritis (LN)

Conditions

  • S100A8
  • Serum
  • Urine
  • Biomarker
  • Lupus
  • Nephritis

Sponsors & Collaborators

  • Theodor Bilharz Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-03-30
Completion
2025-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06872138 on ClinicalTrials.gov